Analyst Price Targets — MDXG
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 27, 2026 3:17 pm | — | Craig-Hallum | $8.00 | $4.54 | TheFly | MiMedx price target raised to $8 from $6 at Craig-Hallum |
| August 17, 2026 12:00 pm | Sarah James | Raymond James | $8.00 | $4.23 | StreetInsider | MiMedx Group (MDXG) Reiterated at Overweight by Cantor Fitzgerald: Wound Care Market Stable |
| July 30, 2026 1:01 pm | — | Lake Street | $7.00 | $3.98 | TheFly | MiMedx price target raised to $7 from $5 at Lake Street |
| February 23, 2026 6:49 am | — | UBS | $10.00 | $5.17 | StreetInsider | Citizens Starts MiMedx Group (MDXG) at Market Outperform |
| November 15, 2024 11:48 am | Anthony Petrone | Mizuho Securities | $16.00 | $9.09 | StreetInsider | MiMedx Group (MDXG) PT Raised to $16 at Mizuho |
| July 2, 2024 6:15 am | Ross Osborn | Cantor Fitzgerald | $11.00 | $6.70 | TheFly | MiMedx initiated with an Overweight at Cantor Fitzgerald |
| April 29, 2024 8:43 am | Brooks O'Neil | Lake Street | $12.00 | $6.27 | TheFly | Proposed new LCDs likely benefit MiMedx if implemented, says Lake Street |
| September 7, 2022 6:20 am | — | H.C. Wainwright | $8.00 | $3.42 | Benzinga | HC Wainwright & Co. Maintains Buy on MiMedx Group, Lowers Price Target to $8 |
Latest News for MDXG
Deutsche Bank AG bought a new position in shares of MiMedx Group, Inc (NASDAQ: MDXG) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 135,153 shares of the company's stock, valued at approximately $520,000. Deutsche Bank AG owned about
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Sanara MedTech Inc. (NasdaqCM: SMTI) to MiMedx Group, Inc. (NasdaqCM: MDXG). Under the terms of the proposed transaction, shareholders of Sanara will receive $33.00 in cash and 0.4735 shares of MiMedx common stock for…
MiMedx Group, Inc. (MDXG) Q2 2026 Earnings Call Transcript
MiMedx Group NASDAQ: MDXG said it has agreed to acquire Sanara MedTech in a transaction valued at $35 per Sanara share, a deal the company expects to close by the end of 2026. The announcement accompanied MiMedx's second-quarter results, which showed sequential improvement in its wound-care business and continued growth in surgical sales.
Reports Second Quarter Net Sales of $64 Million Reiterates Full Year Financial Outlook on a Standalone Basis Announces Plans to Acquire Sanara MedTech Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET MARIETTA, Ga., July 29, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the second quarter 2026.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for MDXG.
U.S. House Trading
No House trades found for MDXG.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.